SCHEMBL6983296

SCHEMBL6983296

COc1ccc2[nH]c3ccc(Cl)cc3c2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.78
KDM4E B2RXH2 3/20 0.78
MEN1 O00255 2/20 0.78
MAPT P10636 2/20 0.78
KMT2A Q03164 2/20 0.78
HSD17B10 Q99714 2/20 0.78
TSHR P16473 1/20 0.78
GFER P55789 1/20 0.78
HPGD P15428 2/20 0.66
ACHE P22303 3/20 0.58
CHUK O15111 1/20 0.57
BCHE P06276 1/20 0.55
ABCG2 Q9UNQ0 1/20 0.54
CNR1 P21554 1/20 0.53
MTNR1A P48039 1/20 0.53
MTNR1B P49286 1/20 0.53
IDO1 P14902 2/20 0.52
MAP2 P11137 1/20 0.52
POLB P06746 2/20 0.51
FLT3 P36888 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27174159 0.91 MAPT (0.65) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL2597652 0.88 ALDH1A1 (1.00) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL29391519 0.88 ALDH1A1 (1.00) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL9709251 0.82 ABCG2 (0.68) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL29453525 0.82 CHUK (0.64) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL607827 0.82 CHUK (0.64) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL22440894 0.81 KDM4E (0.51) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL29562964 0.79 ALDH1A1 (1.00) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL29643258 0.79 ALDH1A1 (1.00) ALDH1A1KDM4EMEN1MAPTKMT2A
Glycozoline SCHEMBL11981403 0.79 ALDH1A1 (0.81) ALDH1A1KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-20020193369-A1 Antifungal compounds and uses therefor PROTEZ PHARMACEUTICALS INC. 2002-12-19 US disclosed
WO-2002036203-A2 AZOLE CONTAINING COMPOSITIONS WITH ENHANCED ANTIFUNGAL ACTIVITY INFLUX, INC. (US) 2002-05-10 WO disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193369-A1 Antifungal compounds and uses therefor CYP51A1, ERG28, TPP1 ALDH1A1 1449/4885KDM4E 2603/4885MEN1 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.